Journal Information
Most often read
157
Prognostic value of abnormal liver function test for hospitalized patients with COVID-19Carlos Alventosa Mateu, Salvador Benlloch, Moisés Diago
Gastroenterol Hepatol. 2024;47:192-3
157
144
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative ColitisFrancisco Rodríguez-Moranta, Federico Argüelles-Arias, Joaquín Hinojosa del Val, Marisa Iborra Colomino, M. Dolores Martín-Arranz, Luis Menchén Viso, Fernando Muñoz Núñez, Elena Ricart Gómez, ... Ana Gutiérrez Casbas
Gastroenterol Hepatol. 2024;47:522-52
144
Full text access
Open Article
75
Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in ArgentinaLisandro Pereyra, Leandro Steinberg, Juan Lasa, Agustina Marconi, Audrey H. Calderwood, María Pellisé
Gastroenterol Hepatol. 2024;47:140-8
75
63
Enteric duplication cyst as a rare presentation of adult acute abdomenGerard Rafart, Clara Bassaganyas, Xavier Morales, Míriam Cuatrecasas, Jordi Rimola
Gastroenterol Hepatol. 2024;47:389-90
63
Full text access
Open Article
59
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: Results of a Delphi studyRocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes, Omar J. Benmarzouk-Hidalgo, Rafael Subirán, Alicia Gil
Gastroenterol Hepatol. 2024;47:337-46
59
Full text access
Open Article
54
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCUMar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, ... María-Carlota Londoño
Gastroenterol Hepatol. 2024;47:401-32
54
Full text access
Open Article
47
An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresisIago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada
Gastroenterol Hepatol. 2024;47:347-51
47
Full text access
Open Article
43
Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processingJose Luis Calleja-Panero, Rafael Esteban Mur, Isidro Jarque, Manuel Romero-Gómez, Savana Research Group, Lucia García Labrador, Jose González Calvo
Gastroenterol Hepatol. 2024;47:236-45
43
Full text access
Open Article
40
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN studyAnum Shaikh, Gabriel Pedra, Leonardo Ruiz-Casas, Bethany Franks, Harpal Dhillon, João Diogo da Rocha Fernandes, Kamal Kant Mangla, Margarida Augusto, ... Jörn M. Schattenberg
Gastroenterol Hepatol. 2024;47:463-72
40
Full text access
Open Article
35
Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathwayYanghui Bi, Liping Zhang, Yan Song, Lijun Sun, Michael W. Mulholland, Yue Yin, Weizhen Zhang
Gastroenterol Hepatol. 2024;47:352-65
35
Full text access
Open Article
32
Black esophagus: Massive bleeding in cirrhosis does not always mean variceal ruptureVítor Macedo Silva, Ana Isabel Ferreira, Pedro Boal Carvalho, Joana Magalhães, José Cotter
Gastroenterol Hepatol. 2024;47:504-5
32
Full text access
Open Article
27
Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM studyDomingo Balderramo, Jesús Yamamoto-Furusho, Enrique Ponce de León, Julio de María, Ignacio Zubiaurre, Silvia Pedreira, Camilo Lis, Laura Brion, Juan A. de Paula
Gastroenterol Hepatol. 2024;47:51-62
27
Full text access
Open Article
22
Extrarenal fibrillary glomerulonephritis as an unknown etiology of advanced liver diseaseCarlos Alventosa Mateu, Ana Vilar Gimeno, Irene Pérez Álvarez, Javier Carbonell Zamorano, Inmaculada Castelló Miralles, Mercedes Latorre Sánchez, Juan José Urquijo Ponce, Encarnación Martínez Leandro, ... Moisés Diago
Gastroenterol Hepatol. 2024;47:381-3
22
8
Gastric medullary carcinoma: A very rare histological variantDavid Hernandez Bermejo, Silvia Carbonell Morote, Cristina Alenda, Sergio Ortiz, Ester Gracia, Emilio Ruiz de la Cuesta, Jose Luis Estrada, Jose Manuel Ramia
Gastroenterol Hepatol. 2024;47:378-9
8
3
Use of multi-gene panels in patients at high risk of hereditary digestive cancer: Position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortiumSabela Carballal, Francesc Balaguer, Luis Bujanda, Gabriel Capellá, Santiago González Santiago, Rodrigo Jover, Leticia Moreira, Marta Pineda, ... Joaquín Cubiella
Gastroenterol Hepatol. 2024;47:293-318
3
3
Leishmania infection in patients with inflammatory bowel disease: Case series and literature reviewLeticia Gimeno-Pitarch, Pedro Almela, Pilar Nos
Gastroenterol Hepatol. 2024;47:82-92
3
1
Duodenal neuroendocrine tumors: Analysis of 24 cases and endoscopic treatment versus surgical treatmentModesto José Varas Lorenzo
Gastroenterol Hepatol. 2024;47:264-5
1
1
Challenging the disease: Esophageal achalasia type II in a patient with myotonic dystrophy type IElena Pérez Campos, Ana Delgado Maroto, José López González
Gastroenterol Hepatol. 2024;47:265-7
1